Telisotuzumab vedotin-tllv
                        
                    
                                    Emrelis
                                
                            
                        
                    
                            1mg
                        
                    
                            C9306
                        
                    
                                    Immunotherapy
                                
                            
                        
                    
                                    Drug Antibody Conjugate
                                
                            
                        
                    
                                    c-MET
                                
                            
                        
                    
                            No
                        
                    
                            2025
                        
                    
                            Sept. 8, 2025
                        
                    
                            In Use
                        
                     An official website of the United States government
 An official website of the United States government
		 Home
 Home 
                             
                    